This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Angeion And Mortara Partner To Produce MedGraphics Ultima™ CardiO2

Angeion Corporation (NASDAQ: ANGN) today announced that it is partnering with Milwaukee, Wis.-based Mortara Instrument, Inc., to produce the Ultima™ CardiO 2 metabolic stress testing system.

Mortara Instrument is a leader in non-invasive electrocardiography (ECG) products. The Ultima CardiO 2, part of Angeion’s MedGraphics product line, incorporates an integrated 12-lead ECG from Mortara Instrument to enhance testing capabilities, making the system a complete metabolic stress testing solution that provides true breath-by-breath analysis. This enables clinicians to quickly and efficiently measure key pulmonary, cardiopulmonary and nutritional functions.

“We first unveiled the Ultima CardiO 2 in 1993. By partnering with Mortara, we are able to enhance the system’s ECG element with the leading electrocardiography technology available today,” said Rodney A. Young, President and Chief Executive Officer of Angeion. “The latest Ultima CardiO 2 is a system that offers complete pulmonary function assessment in hospital laboratories, cardiopulmonary exercise testing in rehabilitation and sports medicine centers, and nutritional assessment in critical care units around the globe.”

The Ultima Series of products offers maximum flexibility to configure both pulmonary function and gas exchange systems to meet clinicians’ current and future diagnostic needs. The Ultima utilizes the latest technology and rapid response sensors for unparalleled performance and reliability. The features and capabilities of the Ultima Series meet the demands of the most exacting clinician.

Dr. Justin Mortara, CEO of Mortara Instrument commented, “We’re excited to partner with Angeion. Just as Mortara Instrument is known worldwide for excellence in diagnostic ECG, MedGraphics is an internationally recognized leader in pulmonary systems. Combining their pulmonary technology with our VERITAS™ ECG algorithms and technology components brings two leaders together, resulting in an excellent solution for cardiopulmonary stress testing. Together, we’re helping clinical professionals at every level access essential information to non-invasively assess and successfully manage their patients’ care across the health continuum.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
AAPL $125.22 -0.91%
FB $83.27 0.09%
GOOG $552.80 0.14%
TSLA $191.81 0.65%
YHOO $44.97 0.04%

Markets

DOW 17,896.80 -79.51 -0.44%
S&P 500 2,082.97 -3.27 -0.16%
NASDAQ 4,939.2780 -8.1630 -0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs